Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial
Harry Bartelink(Radboud University Nijmegen), Laurence Collette(GlaxoSmithKline (Belgium)), H. Struikmans(Radboud University Nijmegen), Carla C. Wárlám-Rodenhuis(Radboud University Nijmegen), Alain Fourquet(Institut Curie), J.J. Jager(Radboud University Nijmegen), M. Piérart(Unknown), W.J. Hoogenraad(Radboud University Nijmegen), Jean-Claude Horiot(Radboud University Nijmegen), S.B. Oei(Radboud University Nijmegen), Walter Van den Bogaert(Radboud University Nijmegen), Philip Poortmans(University of Antwerp)
Cited by 1,045
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k